financetom
Economy
financetom
/
Economy
/
From entry-level Alto to SUV Grand Vitara, Maruti Suzuki increases prices of all its vehicles
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
From entry-level Alto to SUV Grand Vitara, Maruti Suzuki increases prices of all its vehicles
Jan 16, 2023 2:51 AM

India’s largest carmaker Maruti Suzuki, on Monday, hiked prices of its vehicles across models by about 1.1 percent. This is the second price hike that the carmaker is undertaking in the ongoing fiscal year, after increasing it in April 2022.

"An estimated weighted average of increase across models stands at around 1.1 percent. This indicative figure is calculated using ex-showroom prices of models in Delhi and will come into effect from January 16, 2023," the company said in a regulatory filing.

In December 2022, the company had said it would hike the prices of its vehicles to offset the impact of rising input costs and make provisions to update the model range to conform to stricter emission norms which will kick in from April 2023.

Other auto manufacturers like Hyundai, Tata Motors, Audi and Mercedes-Benz have also announced plans to increase prices across their offerings starting January 2023, to partially offset the impact of rising costs. They had said earlier that costs would increase through 2022 amid a shortage of semiconductors, among other factors.

Maruti Suzuki, which sells a range of vehicles - Alto, Baleno, Celerio, Dzire, Ignis, Swift, WagonR and Grand Vitara - stated that the price increases will be based on the specific model and trims.

Prices are going up as car sales in India revive after disruptions caused by COVID-19 and shortages of components including semiconductors. Companies are expanding vehicle production capacities and Maruti Suzuki is building a new factory in Haryana.

Also read: Mahindra announces new Thar RWD starting at Rs 9.99 lakh

(Edited by : Abhishek Jha)

First Published:Jan 16, 2023 11:51 AM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Goldman Sachs: US To Dominate 2025 Growth With 2.5% GDP Boost, Euro Area Will Struggle
Goldman Sachs: US To Dominate 2025 Growth With 2.5% GDP Boost, Euro Area Will Struggle
Nov 16, 2024
Goldman Sachs Research predicts a strong year for global economic growth in 2025, forecasting a 2.7% increase in global GDP on an annual average basis, just above the consensus. The US is expected to lead the way, with GDP growth of 2.5%, significantly surpassing the consensus of 1.9%, Goldman Sachs Research said in a report. The consensus forecast is done...
China willing to be partners, friends with US, Chinese envoy says
China willing to be partners, friends with US, Chinese envoy says
Nov 15, 2024
SHANGHAI (Reuters) -China is willing to be partners and friends with the United States, China's ambassador to Washington said, seeking to strengthen dialogue between the world's two largest economies. China has no plan to surpass or replace the United States, Xie Feng said in a speech in Hong Kong on Friday, addressing Chinese officials and the U.S. ambassador to China....
Economics Professor Doubts Impact Of Dogecoin-Inspired, Elon Musk-Led Department On Federal Deficit, Cites This As Major Concern
Economics Professor Doubts Impact Of Dogecoin-Inspired, Elon Musk-Led Department On Federal Deficit, Cites This As Major Concern
Nov 18, 2024
A Washington State University economics professor has cast doubt on the effectiveness of the newly proposed Department of Government Efficiency named after cryptocurrency Dogecoin (CRYPTO: DOGE) in addressing the federal deficit, highlighting data showing most government spending goes to entitlement programs rather than bureaucratic salaries. What Happened: Christopher Clarke, assistant professor at WSU’s School of Economic Sciences, pointed to long-term...
Goldman Sachs Economist: Weight-Loss Drugs Could Be Key To US Economic Growth
Goldman Sachs Economist: Weight-Loss Drugs Could Be Key To US Economic Growth
Nov 17, 2024
A Goldman Sachs economist has suggested that the US economy could experience accelerated growth with increased use of GLP-1 weight-loss drugs like Ozempic. What Happened: Jan Hatzius, chief economist at Goldman Sachs, has said that US GDP could potentially grow an additional 1% if 60 million Americans were to use GLP-1 drugs by 2028. Hatzius pointed out that health-related issues...
Copyright 2023-2025 - www.financetom.com All Rights Reserved